Chronic active T cell–mediated rejection is variably responsive to immunosuppressive therapy

Autor: Kung, Vanderlene L., Sandhu, Rana, Haas, Mark, Huang, Edmund

Publikováno v: In Kidney International August 2021 100(2):391-400

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Biomarkers and novel therapeutic approaches for diffuse large B-cell lymphoma in the era of precision medicine.

Autor: Lodhi N; Department of Immunotherapeutic and Biotechnology, Texas Tech Health Science Center, Abilene, TX, USA.; Formerly: The Genomics and Biomarkers Program, John Theurer Cancer Center at Hackensack University Medical Center, David Jurist Research Building, Hackensack, NJ, USA.; These authors contributed equally to this work., Tun M; Formerly: The Genomics and Biomarkers Program, John Theurer Cancer Center at Hackensack University Medical Center, David Jurist Research Building, Hackensack, NJ, USA.; These authors contributed equally to this work., Nagpal P; Formerly: The Genomics and Biomarkers Program, John Theurer Cancer Center at Hackensack University Medical Center, David Jurist Research Building, Hackensack, NJ, USA.; College of Natural, Applied, and Health Sciences, Kean University, Union, NJ, USA., Inamdar AA; Formerly: The Genomics and Biomarkers Program, John Theurer Cancer Center at Hackensack University Medical Center, David Jurist Research Building, Hackensack, NJ, USA., Ayoub NM; Department of Clinical Pharmacy, Jordan University of Science and Technology, Irbid, Jordan., Siyam N; Formerly: The Genomics and Biomarkers Program, John Theurer Cancer Center at Hackensack University Medical Center, David Jurist Research Building, Hackensack, NJ, USA., Oton-Gonzalez L; Department of Medical Sciences, University of Ferrara, Ferrara, Italy., Gerona A; Formerly: The Genomics and Biomarkers Program, John Theurer Cancer Center at Hackensack University Medical Center, David Jurist Research Building, Hackensack, NJ, USA., Morris D; Formerly: The Genomics and Biomarkers Program, John Theurer Cancer Center at Hackensack University Medical Center, David Jurist Research Building, Hackensack, NJ, USA., Sandhu R; Formerly: The Genomics and Biomarkers Program, John Theurer Cancer Center at Hackensack University Medical Center, David Jurist Research Building, Hackensack, NJ, USA., Suh KS; Formerly: The Genomics and Biomarkers Program, John Theurer Cancer Center at Hackensack University Medical Center, David Jurist Research Building, Hackensack, NJ, USA.; DiagnoCine, Hackensack, NJ, USA.

Publikováno v: Oncotarget [Oncotarget] 2020 Nov 03; Vol. 11 (44), pp. 4045-4073. Date of Electronic Publication: 2020 Nov 03 (Print Publication: 2020).